全文获取类型
收费全文 | 1249篇 |
免费 | 81篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 79篇 |
妇产科学 | 12篇 |
基础医学 | 110篇 |
口腔科学 | 31篇 |
临床医学 | 105篇 |
内科学 | 283篇 |
皮肤病学 | 25篇 |
神经病学 | 32篇 |
特种医学 | 305篇 |
外科学 | 88篇 |
综合类 | 61篇 |
预防医学 | 67篇 |
眼科学 | 21篇 |
药学 | 42篇 |
中国医学 | 9篇 |
肿瘤学 | 57篇 |
出版年
2021年 | 4篇 |
2020年 | 6篇 |
2019年 | 10篇 |
2018年 | 16篇 |
2017年 | 11篇 |
2016年 | 8篇 |
2015年 | 19篇 |
2014年 | 42篇 |
2013年 | 64篇 |
2012年 | 35篇 |
2011年 | 33篇 |
2010年 | 39篇 |
2009年 | 66篇 |
2008年 | 36篇 |
2007年 | 52篇 |
2006年 | 35篇 |
2005年 | 33篇 |
2004年 | 26篇 |
2003年 | 22篇 |
2002年 | 26篇 |
2001年 | 22篇 |
2000年 | 24篇 |
1999年 | 22篇 |
1998年 | 81篇 |
1997年 | 55篇 |
1996年 | 65篇 |
1995年 | 46篇 |
1994年 | 54篇 |
1993年 | 46篇 |
1992年 | 11篇 |
1991年 | 12篇 |
1990年 | 17篇 |
1989年 | 40篇 |
1988年 | 32篇 |
1987年 | 29篇 |
1986年 | 23篇 |
1985年 | 12篇 |
1984年 | 20篇 |
1983年 | 17篇 |
1982年 | 15篇 |
1981年 | 20篇 |
1980年 | 13篇 |
1979年 | 9篇 |
1978年 | 11篇 |
1977年 | 16篇 |
1976年 | 9篇 |
1975年 | 12篇 |
1968年 | 4篇 |
1967年 | 4篇 |
1966年 | 2篇 |
排序方式: 共有1339条查询结果,搜索用时 15 毫秒
41.
Two patients with hairy cell leukemia with massive splenomegaly and severe pancytopenia were treated with recombinant alpha-A interferon (IFN-alpha-2a). There was no significant response to a trial of IFN- alpha-2a (11 and 20 weeks) with respect to blood counts or spleen size. Subsequent treatment with 2'-deoxycoformycin (dCF) for 8 consecutive weeks (4 mg/m2/wk) resulted in normalization of spleen size and a normalization of peripheral blood counts and bone marrow in one patient. The second patient demonstrated a reduction in spleen size and improved blood counts following 9 weeks of dCF therapy but eventually became refractory. This demonstrates that dCF is non-cross-resistant with interferon and confirms the efficacy of dCF in nonsplenectomized patients. 相似文献
42.
43.
44.
van Rijk MC Tanis PJ Nieweg OE Loo CE Olmos RA Oldenburg HS Rutgers EJ Hoefnagel CA Kroon BB 《Annals of surgical oncology》2007,14(2):627-632
Background Preliminary data have shown encouraging results of a single intratumoral radiopharmaceutical injection that enables both sentinel
node biopsy and probe-guided excision of the primary tumor in patients with nonpalpable breast cancer. The aim of the study
was to evaluate this approach in a large group of patients.
Methods Lymphoscintigraphy was performed in 368 patients with nonpalpable breast cancer after intratumoral injection of 99mTc-nanocolloid (.2 mL, 123 MBq, 3.3 mCi) guided by ultrasound or stereotaxis. The sentinel node was pursued with the aid of
vital blue dye (1.0 mL, intratumoral) and a gamma ray detection probe. In case of breast-conserving surgery, the probe was
used to guide the excision.
Results At least one sentinel node could be identified intraoperatively in 357 patients (97%), of whom 69 had involved nodes (19%).
Age over 60 years was associated with less frequent nonaxillary lymphatic drainage and absence of internal mammary chain dissemination.
Tumor-free margins were obtained in 262 (89%) of the 293 patients who underwent segmental excision. Re-excision of the primary
tumor bed was performed in six patients (2%). During a median follow-up of 22 months, one breast recurrence and one axillary
recurrence were observed.
Conclusions Lymphatic mapping and probe-guided tumor excision of nonpalpable breast cancer by intralesional administration of a single
dose of 99mTc-nanocolloid and blue dye resulted in 97% identification of the sentinel node and in tumor-free margins in 89% of the patients
who underwent breast-conserving surgery. Longer follow-up is needed to substantiate the accuracy and safety of this technique. 相似文献
45.
目的探讨经关节入路微创钢板固定(MIPPO)技术治疗股骨远端C型骨折的临床疗效。方法2002年4月~2005年2月,应用MIPPO技术治疗股骨远端C型骨折14例,按AO/ASIF分类:C1型3例,C2型6例,C3型5例。先行关节内骨折切开复位、松质骨螺钉固定,再行髁上部分骨折间接复位、经关节内切口插入髁支撑钢板或LISS钢板桥接固定骨折。结果12例患者获得10~32个月(平均18.4个月)随访,骨折均获愈合,愈合时间10周~12个月,平均4.6个月。按Kolmert和Wulff的评价标准:优4例,良5例,可2例,差1例,优良率为75%。结论应用MIPPO技术治疗股骨远端C型骨折实现了微创操作,具有创伤小、软组织干扰少、骨折愈合快等优点,疗效满意。 相似文献
46.
High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients 总被引:1,自引:1,他引:1
High-dose intravenous gammaglobulin (polyvalent immunoglobulin G) has been shown to be of benefit in some patients with immune thrombocytopenic purpura (ITP), possibly by producing reticuloendothelial system blockade. We studied this approach in patients refractory to random donor platelet transfusion using an IV IgG preparation manufactured by the Swiss Red Cross. Eleven adult patients with acute leukemia received either 0.4 g IgG/kg/d intravenously X five days (four patients) or 0.6 g/kg/d X five days (seven patients). All patients had high levels of lymphocytotoxic antibody and poor responses to random donor platelets. Except for mild headaches in two patients, there were no side effects related to the IgG infusions. All patients had significant elevations of serum IgG on the day after completion of treatment. Either random donor or partially HLA-matched platelet transfusions were administered the day after and, in some cases, during the IgG therapy. No patient had an improvement in one hour posttransfusion platelet count increments. Two additional patients received pooled platelet concentrates incubated for 30 minutes at 37 degrees C with IgG at a final concentration of 3 g% prior to transfusions. These results indicate that high-dose IgG, an extremely expensive treatment, cannot be recommended for alloimmunized adults with leukemia. 相似文献
47.
48.
49.
CA Tan D. del Gaudio M.A. Dempsey K. Arndt S. Botes A. Reeder S. Das 《Clinical genetics》2014,85(4):353-358
Primary Autosomal Recessive Microcephaly (MCPH) is characterized by congenital microcephaly usually without additional clinical findings. The most common gene implicated in MCPH is ASPM and a large percentage of mutations described have been homozygous and in consanguineous families primarily of East Asian and Middle Eastern origin. ASPM sequencing was performed on 400 patients between the years 2009 and 2012. Seventy of the patient samples were also analyzed for copy number changes in the ASPM gene. Forty protein truncating mutations, including 29 novel mutations, were identified in 39 patients with MCPH. Approximately one third of patients were compound heterozygotes, indicative of non‐consanguinity in these patients. In addition, 46 non‐synonymous variants were identified and interpreted as variants of uncertain significance. No deletion/duplication in ASPM was identified in the patients analyzed. A wide ethnic distribution was observed, including the first reported patients with ASPM‐related MCPH of Hispanic descent. Clinical information was collected for 26 of the ASPM‐positive patients and 41 of the ASPM‐negative patients. As more individuals are identified with MCPH, we anticipate that we will continue to identify ASPM mutation‐positive patients from all ethnic origins supporting the occurrence of this genetic condition beyond that of consanguineous families of certain ethnic populations. 相似文献
50.
目的 白细胞介素 1 3(IL 1 3)是新近发现的一种抗炎性细胞因子 ,其在肾小球肾炎中的作用尚不清楚 ,该研究探讨脂多糖 (LPS)对体外培养的人肾小球系膜细胞 (HMC)表达IL 1 3作用以及IL 1 3对HMC促炎性细胞因子、趋化因子和促纤维化因子基因表达的影响。方法 体外培养HMC ,加入不同浓度的LPS和 (或 )IL 1 3后 ,用逆转录 -聚合酶链反应和ELISA检测HMCIL 1 3mRNA表达和细胞培养上清液中IL 1 3蛋白含量 ;应用核酸酶保护法检测HMC肿瘤坏死因子 α(TNF α)、白介素 - 1α(IL 1α)、白介素 - 1 β(IL 1 β)、单核细胞趋化蛋白 1(MCP 1 )、白介素 8(IL 8)、转化生长因子 - β1 (TGF β1 )mRNA的表达。 结果 未予LPS刺激的HMC不表达IL 1 3mRNA和蛋白 ;LPS呈剂量依赖性和时间依赖性诱导HMC表达IL 1 3mRNA和分泌IL 1 3蛋白。HMC受LPS刺激后 1 2h即可表达IL 1 3mRNA ,4 8h达高峰 ,72h仍维持在较高的水平。HMC受LPS刺激后 2 4h ,其培养上清液中检测到IL 1 3蛋白 ,4 8h和 72h进一步增加。外源性IL 1 3呈剂量依赖性地抑制LPS诱导的系膜细胞TNF α ,IL 1α ,IL 1 β ,MCP 1 ,IL 8,TGF β1mRNA的表达。应用抗IL 1 3抗体中和内源性IL 1 3后 ,上述炎症因子表达增强。结论 IL 1 3是HMC自分泌因子。IL 1 3可抑制LPS诱导 相似文献